[1]
D. Paul, “Pharmacogenomic Profiling of DPYD Mutations and Genotype‑guided Dose Adjustment to Prevent Fluoropyrimidine Toxicity in Gastrointestinal Cancer Patients: A Real‑world Study from North India”, apjcc, vol. 10, no. 4, pp. 1093-1100, Dec. 2025.